Literature DB >> 11239857

Treatment of idiopathic pulmonary fibrosis: the rise and fall of corticosteroids.

H R Collard, T E King.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11239857     DOI： 10.1016/s0002-9343(01)00622-2

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  8 in total

1.  Targeting of Discoidin Domain Receptor 2 (DDR2) Prevents Myofibroblast Activation and Neovessel Formation During Pulmonary Fibrosis.

Authors:  Hu Zhao; Huan Bian; Xin Bu; Shuya Zhang; Pan Zhang; Jiangtian Yu; Xiaofeng Lai; Di Li; Chuchao Zhu; Libo Yao; Jin Su
Journal:  Mol Ther       Date:  2016-05-27       Impact factor: 11.454

2.  Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis.

Authors:  Moises Selman; Hung-Mo Lin; Martha Montaño; Audrey L Jenkins; Andrea Estrada; Zhenwu Lin; Guirong Wang; Susan L DiAngelo; Xiaoxuan Guo; Todd M Umstead; C Max Lang; Annie Pardo; David S Phelps; Joanna Floros
Journal:  Hum Genet       Date:  2003-09-06       Impact factor: 4.132

3.  Pivotal role of cathepsin K in lung fibrosis.

Authors:  Frank Bühling; Christoph Röcken; Frank Brasch; Roland Hartig; Yoshiyuki Yasuda; Paul Saftig; Dieter Brömme; Tobias Welte
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

4.  Global methylation patterns in idiopathic pulmonary fibrosis.

Authors:  Einat I Rabinovich; Maria G Kapetanaki; Israel Steinfeld; Kevin F Gibson; Kusum V Pandit; Guoying Yu; Zohar Yakhini; Naftali Kaminski
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

Review 5.  Growth factors in idiopathic pulmonary fibrosis: relative roles.

Authors:  Jeremy T Allen; Monica A Spiteri
Journal:  Respir Res       Date:  2001-11-28

6.  Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis.

Authors:  Annie Pardo; Kevin Gibson; José Cisneros; Thomas J Richards; Yinke Yang; Carina Becerril; Samueal Yousem; Iliana Herrera; Victor Ruiz; Moisés Selman; Naftali Kaminski
Journal:  PLoS Med       Date:  2005-09-06       Impact factor: 11.069

7.  Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis.

Authors:  Frank Bühling; Aline Wille; Christoph Röcken; Olaf Wiesner; Anja Baier; Ingmar Meinecke; Tobias Welte; Thomas Pap
Journal:  Respir Res       Date:  2005-04-17

8.  Attenuation of Bleomycin-Induced Pulmonary Fibrosis in Rats with S-Allyl Cysteine.

Authors:  Takuma Tsukioka; Shigekazu Takemura; Yukiko Minamiyama; Shinjiro Mizuguchi; Michihito Toda; Shigeru Okada
Journal:  Molecules       Date:  2017-03-29       Impact factor: 4.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.